Intravitreous vascular endothelial growth factor (VEGF) inhibitor therapy for tamoxifen induced macular edema. uri icon

Overview

abstract

  • A 59-year-old male patient with tamoxifen induced macular edema in both eyes was treated with intravitreous sodium pegaptanib. Follow-up clinical examination, OCT, and FA demonstrated reduced edema and leakage with improvement in visual acuity.

publication date

  • January 1, 2007

Research

keywords

  • Antineoplastic Agents, Hormonal
  • Aptamers, Nucleotide
  • Macular Edema
  • Tamoxifen
  • Vascular Endothelial Growth Factor A

Identity

Scopus Document Identifier

  • 34250347204

Digital Object Identifier (DOI)

  • 10.1080/08820530701418524

PubMed ID

  • 17564928

Additional Document Info

volume

  • 22

issue

  • 2